A stapled peptide-based PROTAC (SP-PROTAC) was designed to specifically destroy palmitoyl-transferase (DHHC3), which led to the reduction of PD-L1 in cervical cancer cell lines. This evidence concerns the gene CD274 and cervical cancer.